mounjaro tirzepatide news today september 2025 Eli Lilly's shows cardiovascular gains, but analysts underwhelmed Mounjaro (tirzepatide) receives positive CHMP

How CagriSema Compares With Current GLP-1 Medications One of the biggest questions people have is how CagriSema compares with medications such as Wegovy, Zepbound, or Mounjaro

Additionally, approximately 70-80% of semaglutide (Wegovy) users lost more than 5% of body weight

However, the specific pattern of GLP-1 system dysfunction appears to differ across conditions

Differentiation of the mesenchymal stem cells to pancreatic beta-like cells in alginate/trimethyl chitosan/alginate microcapsules

10.1161/ATVBAHA.120.314515 Arterioscler Thromb Vasc Biol

Eli Lilly added that it has invested more than $18 billion to update its existing US manufacturing facilities